Copyright Reports & Markets. All rights reserved.

Global Sterile Injectable Drugs Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Sterile Injectable Drugs Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Sterile Injectable Drugs Market Size Growth Rate by Product
      • 1.4.2 Cytokines
      • 1.4.3 Insulin
      • 1.4.4 Peptide hormones
      • 1.4.5 Vaccines
      • 1.4.6 Immunoglobulins
      • 1.4.7 Blood Factors
      • 1.4.8 Peptide antibiotics
      • 1.4.9 Others
    • 1.5 Market by End User
      • 1.5.1 Global Sterile Injectable Drugs Market Size Growth Rate by End User
      • 1.5.2 Cancer
      • 1.5.3 Diabetes
      • 1.5.4 Cardiovascular Diseases
      • 1.5.5 Musculoskeletal
      • 1.5.6 CNS
      • 1.5.7 Infections
      • 1.5.8 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Sterile Injectable Drugs Market Size
      • 2.1.1 Global Sterile Injectable Drugs Revenue 2014-2025
      • 2.1.2 Global Sterile Injectable Drugs Sales 2014-2025
    • 2.2 Sterile Injectable Drugs Growth Rate by Regions
      • 2.2.1 Global Sterile Injectable Drugs Sales by Regions
      • 2.2.2 Global Sterile Injectable Drugs Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Sterile Injectable Drugs Sales by Manufacturers
      • 3.1.1 Sterile Injectable Drugs Sales by Manufacturers
      • 3.1.2 Sterile Injectable Drugs Sales Market Share by Manufacturers
      • 3.1.3 Global Sterile Injectable Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.2 Sterile Injectable Drugs Revenue by Manufacturers
      • 3.2.1 Sterile Injectable Drugs Revenue by Manufacturers (2014-2019)
      • 3.2.2 Sterile Injectable Drugs Revenue Share by Manufacturers (2014-2019)
    • 3.3 Sterile Injectable Drugs Price by Manufacturers
    • 3.4 Sterile Injectable Drugs Manufacturing Base Distribution, Product Types
      • 3.4.1 Sterile Injectable Drugs Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Sterile Injectable Drugs Product Type
      • 3.4.3 Date of International Manufacturers Enter into Sterile Injectable Drugs Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Sterile Injectable Drugs Sales by Product
    • 4.2 Global Sterile Injectable Drugs Revenue by Product
    • 4.3 Sterile Injectable Drugs Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Sterile Injectable Drugs Breakdown Data by End User

    6 North America

    • 6.1 North America Sterile Injectable Drugs by Countries
      • 6.1.1 North America Sterile Injectable Drugs Sales by Countries
      • 6.1.2 North America Sterile Injectable Drugs Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Sterile Injectable Drugs by Product
    • 6.3 North America Sterile Injectable Drugs by End User

    7 Europe

    • 7.1 Europe Sterile Injectable Drugs by Countries
      • 7.1.1 Europe Sterile Injectable Drugs Sales by Countries
      • 7.1.2 Europe Sterile Injectable Drugs Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Sterile Injectable Drugs by Product
    • 7.3 Europe Sterile Injectable Drugs by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Sterile Injectable Drugs by Countries
      • 8.1.1 Asia Pacific Sterile Injectable Drugs Sales by Countries
      • 8.1.2 Asia Pacific Sterile Injectable Drugs Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Sterile Injectable Drugs by Product
    • 8.3 Asia Pacific Sterile Injectable Drugs by End User

    9 Central & South America

    • 9.1 Central & South America Sterile Injectable Drugs by Countries
      • 9.1.1 Central & South America Sterile Injectable Drugs Sales by Countries
      • 9.1.2 Central & South America Sterile Injectable Drugs Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Sterile Injectable Drugs by Product
    • 9.3 Central & South America Sterile Injectable Drugs by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Sterile Injectable Drugs by Countries
      • 10.1.1 Middle East and Africa Sterile Injectable Drugs Sales by Countries
      • 10.1.2 Middle East and Africa Sterile Injectable Drugs Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Sterile Injectable Drugs by Product
    • 10.3 Middle East and Africa Sterile Injectable Drugs by End User

    11 Company Profiles

    • 11.1 Baxter International
      • 11.1.1 Baxter International Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Baxter International Sterile Injectable Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Baxter International Sterile Injectable Drugs Products Offered
      • 11.1.5 Baxter International Recent Development
    • 11.2 Sanofi
      • 11.2.1 Sanofi Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Sanofi Sterile Injectable Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Sanofi Sterile Injectable Drugs Products Offered
      • 11.2.5 Sanofi Recent Development
    • 11.3 GlaxoSmithKline
      • 11.3.1 GlaxoSmithKline Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 GlaxoSmithKline Sterile Injectable Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 GlaxoSmithKline Sterile Injectable Drugs Products Offered
      • 11.3.5 GlaxoSmithKline Recent Development
    • 11.4 AstraZeneca
      • 11.4.1 AstraZeneca Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 AstraZeneca Sterile Injectable Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 AstraZeneca Sterile Injectable Drugs Products Offered
      • 11.4.5 AstraZeneca Recent Development
    • 11.5 Merck
      • 11.5.1 Merck Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Merck Sterile Injectable Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Merck Sterile Injectable Drugs Products Offered
      • 11.5.5 Merck Recent Development
    • 11.6 Novartis
      • 11.6.1 Novartis Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Novartis Sterile Injectable Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Novartis Sterile Injectable Drugs Products Offered
      • 11.6.5 Novartis Recent Development
    • 11.7 Pfizer
      • 11.7.1 Pfizer Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Pfizer Sterile Injectable Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Pfizer Sterile Injectable Drugs Products Offered
      • 11.7.5 Pfizer Recent Development
    • 11.8 GILEAD SCIENCES
      • 11.8.1 GILEAD SCIENCES Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 GILEAD SCIENCES Sterile Injectable Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 GILEAD SCIENCES Sterile Injectable Drugs Products Offered
      • 11.8.5 GILEAD SCIENCES Recent Development
    • 11.9 Johnson & Johnson Services
      • 11.9.1 Johnson & Johnson Services Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Johnson & Johnson Services Sterile Injectable Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Johnson & Johnson Services Sterile Injectable Drugs Products Offered
      • 11.9.5 Johnson & Johnson Services Recent Development

    12 Future Forecast

    • 12.1 Sterile Injectable Drugs Market Forecast by Regions
      • 12.1.1 Global Sterile Injectable Drugs Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Sterile Injectable Drugs Revenue Forecast by Regions 2019-2025
    • 12.2 Sterile Injectable Drugs Market Forecast by Product
      • 12.2.1 Global Sterile Injectable Drugs Sales Forecast by Product 2019-2025
      • 12.2.2 Global Sterile Injectable Drugs Revenue Forecast by Product 2019-2025
    • 12.3 Sterile Injectable Drugs Market Forecast by End User
    • 12.4 North America Sterile Injectable Drugs Forecast
    • 12.5 Europe Sterile Injectable Drugs Forecast
    • 12.6 Asia Pacific Sterile Injectable Drugs Forecast
    • 12.7 Central & South America Sterile Injectable Drugs Forecast
    • 12.8 Middle East and Africa Sterile Injectable Drugs Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Sterile Injectable Drugs Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Sterile injectable drugs are sterile, parenteral preparations containing one more Active Pharmaceutical Ingredient (API) intended for administration into the body.
      Growth of the global sterile injectable drugs is primarily driven by increasing demand for novel drug delivery systems, rising prevalence of chronic diseases, increasing public private partnerships and also rising awareness towards the use of sterile injectable drugs.
      The global Sterile Injectable Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Sterile Injectable Drugs market based on company, product type, end user and key regions.

      This report studies the global market size of Sterile Injectable Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Sterile Injectable Drugs in these regions.
      This research report categorizes the global Sterile Injectable Drugs market by top players/brands, region, type and end user. This report also studies the global Sterile Injectable Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Baxter International
      Sanofi
      GlaxoSmithKline
      AstraZeneca
      Merck
      Novartis
      Pfizer
      GILEAD SCIENCES
      Johnson & Johnson Services

      Market size by Product
      Cytokines
      Insulin
      Peptide hormones
      Vaccines
      Immunoglobulins
      Blood Factors
      Peptide antibiotics
      Others
      Market size by End User
      Cancer
      Diabetes
      Cardiovascular Diseases
      Musculoskeletal
      CNS
      Infections
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Sterile Injectable Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Sterile Injectable Drugs market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Sterile Injectable Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Sterile Injectable Drugs submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Sterile Injectable Drugs are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Sterile Injectable Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now